Trial Profile
Effects of Dapagliflozin on Epicardial Fat in Subjects With Type 2 Diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Feb 2021
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary) ; Metformin
- Indications Obesity; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 07 Jan 2021 Status changed from active, no longer recruiting to completed.
- 05 Nov 2020 Planned End Date changed from 1 Dec 2020 to 1 Jun 2021.
- 05 Nov 2020 Planned primary completion date changed from 1 Dec 2020 to 1 Feb 2021.